Crlcc Eugene Marquis

Rennes 35042

2 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, Esophageal Squamous Cell Carcinoma, Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Metastatic Colorectal Cancer, Ovarian Cancer

Studies at this site

• A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• TheraSphere With Durvalumab and Tremelimumab for HCC — Running, not enrolling
• A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) — Stopped early
• A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
• Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer — Completed